4-((tert-Butoxycarbonyl)amino)-1-methyl-1H-pyrazole-3-carboxylic acid, 98%, 250mg

({[1,1'-biphenyl]-4-yl}methyl)(propyl)amine, 95.0%, 2g

3-Bromo-4-chlorothiophenol, 1g

[S(R)]-N-[(R)-[2-(Diphenylphosphino)phenyl](4-methoxyphenyl)methyl]-2-methyl-2-propanesulfinamide, 95%, 25mg

2,3,4,6-TETRA-O-BENZYL-D-GALACTOPYRANOSE, 98%, 100g

4-Methylpyridine-3-sulfonyl chloride, 95.0%, 500mg

8-Bromo-4-hydroxy-2-(trifluoromethyl)quinoline, 95.0%, 1g

Methyl 5-amino-2-chloroisonicotinate, 95.0%, 5g

6-(1,4-Diazepan-1-yl)nicotinonitrile, 95.0%, 1g

4-(Bromomethyl)-1-methoxy-2-nitrobenzene, 95.0%, 100mg

(1S,3S)-3-Aminocyclopentanecarboxylic acid hydrochloride, 97%, 1g

Chromatography columns with frit, ground glass core and GL 18 extraction connection, 430 ml, 30 mm, 600 mm, 1 Piece(s)

1-[(benzyloxy)carbonyl]-5,5-difluoropiperidine-3-carboxylic acid, 97.0%, 250mg